Search
Back

Olanzapine

CAS 132539-06-1
Olanzapine

General Information

About the API

Technology Synthetic
Therapeutic category Neurology-Psychiatry
Available formulations Injectables Oral Solid
Regulations
  • Japan DMF
  • Korea DMF
  • US DMF

Updates About Olanzapine

January 25, 2016
Recently we have received approval in Taiwan.

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.